• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

5
5
5
5
5

COUNTRY

5
1

CATEGORIES

  • 11
  • 4
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 1

PRICE

5
5
18
31

PUBLISHED

1
3
8
31

PRODUCT TYPE

23
8

Search "Medicure Inc.-Detailed Product Pipeline" returned 31 results.

Medicure Inc. - Product Pipeline Review - 2013

Medicure Inc. - Product Pipeline Review - 2013 Summary “Medicure Inc. - Product Pipeline Review - 2013” provides data on the Medicure Inc.’s research and development focus. The report includes information...

December 2013
FROM

Medicure Inc. - Product Pipeline Review - 2014

Medicure Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘Medicure Inc. - Product Pipeline Review - 2014’, provides an overview of the Medicure Inc.’s pharmaceutical research...

June 2014
FROM

Medicure Inc. - Product Pipeline Review - 2012

Medicure Inc. – Product Pipeline Review – 2012 Summary Global Market Direct’s pharmaceuticals report, “Medicure Inc. - Product Pipeline Review - 2012” provides data on the Medicure Inc.’s research...

November 2012
FROM

Medicure Inc. - Product Pipeline Review - Q1 2011

Medicure Inc. – Product Pipeline Review – Q1 2011 Summary Global Market Direct’s pharmaceuticals report, “Medicure Inc. - Product Pipeline Review - Q1 2011” provides data on the Medicure Inc.’s research...

June 2011
FROM

Medicure Inc. - Product Pipeline Review - Q4 2010

Medicure Inc. – Product Pipeline Review – Q4 2010 Summary Global Market Direct’s pharmaceuticals report, “Medicure Inc. - Product Pipeline Review - Q4 2010” provides data on the company’s research...

November 2010
FROM

Medicure Inc. - Product Pipeline Review - Q4 2010

Medicure Inc. – Product Pipeline Review – Q4 2010 Summary Global Market Direct’s pharmaceuticals report, “Medicure Inc. - Product Pipeline Review - Q4 2010” provides data on the company’s research...

November 2010
FROM

Tardive Dyskinesia - Pipeline Review, H1 2015

Tardive Dyskinesia - Pipeline Review, H1 2015 Summary This, ‘Tardive Dyskinesia - Pipeline Review, H1 2015’, provides an overview of the Tardive Dyskinesia’s therapeutic pipeline. This report provides...

January 2015
FROM

Tardive Dyskinesia - Pipeline Review, H2 2014

Tardive Dyskinesia - Pipeline Review, H2 2014 Summary This, ‘Tardive Dyskinesia - Pipeline Review, H2 2014’, provides an overview of the Tardive Dyskinesia’s therapeutic pipeline. This report provides...

December 2014
FROM

Endacea, Inc. - Product Pipeline Review - 2012

Endacea, Inc. – Product Pipeline Review – 2012 Summary Global Market Direct’s pharmaceuticals report, “Endacea, Inc. - Product Pipeline Review - 2012” provides data on the Endacea, Inc.’s research...

December 2012
FROM

Thrombosis - Pipeline Review, H2 2014

Thrombosis - Pipeline Review, H2 2014 Summary This, ‘Thrombosis - Pipeline Review, H2 2014’, provides an overview of the Thrombosis’s therapeutic pipeline. This report provides comprehensive information...

December 2014
FROM

Dyskinesia - Pipeline Review, H1 2015

Dyskinesia - Pipeline Review, H1 2015 Summary This, ‘Dyskinesia - Pipeline Review, H1 2015’, provides an overview of the Dyskinesia’s therapeutic pipeline. This report provides comprehensive information...

March 2015
FROM

Acute Coronary Syndrome - Pipeline Review, H1 2014

Acute Coronary Syndrome - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Acute Coronary Syndrome - Pipeline Review, H1 2014’, provides an overview of the Acute Coronary Syndrome’s therapeutic...

March 2014
FROM

Myocardial Infarction- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment

“ Myocardial Infarction- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014” provides comprehensive insights about phase III pipeline drugs and marketed drugs across the...

July 2015
FROM

B. Braun Melsungen AG - Strategic SWOT Analysis Review

B. Braun Melsungen AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed...

May 2015
FROM

Coronary Artery Disease (CAD) (Ischemic Heart Disease) - Pipeline Review, H1 2015

Coronary Artery Disease (CAD) (Ischemic Heart Disease) - Pipeline Review, H1 2015 Summary This, ‘Coronary Artery Disease (CAD) (Ischemic Heart Disease) - Pipeline Review, H1 2015’, provides an overview...

January 2015
FROM

Kidney Disease - Pipeline Review, H1 2014

Kidney Disease - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Kidney Disease - Pipeline Review, H1 2014’, provides an overview of the Kidney Disease’s therapeutic pipeline. This report...

March 2014
FROM

India Nephrology and Urology Devices Investment Opportunities, Analysis and Forecasts to 2015

India Nephrology and Urology Devices Investment Opportunities, Analysis and Forecasts to 2015 Summary This report is an essential source for in-depth information and data relating to India nephrology...

July 2009
FROM

The Medicines Company (MDCO) - Financial and Strategic SWOT Analysis Review

The Medicines Company (MDCO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled...

June 2015
FROM

Germany Wound Care Management Investment Opportunities, Analysis and Forecasts to 2015

Germany Wound Care Management Investment Opportunities, Analysis and Forecasts to 2015 Summary This report is an essential source for in-depth information and data relating to Germany wound care management...

August 2009
FROM

New Oral Anticoagulants Markets

Anticoagulants decrease the ability of the blood to create harmful blood clots that can ultimately leading to a heart attack or stroke Although sometimes referred to as blood thinners, they do not actually...

March 2013
FROM
Loading Indicator

Our Clients

Amneal Pharmaceuticals LLC. Amgen Inc. LEO Laboratories Ltd. Pfizer, Inc. Roche Diagnostics Ltd. Merck & Co., Inc. Sanofi S.A.